Eurobio Scientific Société anonyme Management
Management criteria checks 1/4
Eurobio Scientific Société anonyme's CEO is Denis Fortier, appointed in Mar 2017, has a tenure of 7.83 years. total yearly compensation is €1.30M, comprised of 23.1% salary and 76.9% bonuses, including company stock and options. directly owns 0.057% of the company’s shares, worth €146.08K. The average tenure of the management team and the board of directors is 1.4 years and 7.6 years respectively.
Key information
Denis Fortier
Chief executive officer
€1.3m
Total compensation
| CEO salary percentage | 23.1% |
| CEO tenure | 7.8yrs |
| CEO ownership | 0.06% |
| Management average tenure | 1.4yrs |
| Board average tenure | 7.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | €7m |
| Mar 31 2024 | n/a | n/a | €6m |
| Dec 31 2023 | €1m | €300k | €5m |
| Sep 30 2023 | n/a | n/a | €6m |
| Jun 30 2023 | n/a | n/a | €8m |
| Mar 31 2023 | n/a | n/a | €16m |
| Dec 31 2022 | €300k | €300k | €25m |
| Sep 30 2022 | n/a | n/a | €36m |
| Jun 30 2022 | n/a | n/a | €47m |
| Mar 31 2022 | n/a | n/a | €54m |
| Dec 31 2021 | €300k | €300k | €61m |
| Sep 30 2021 | n/a | n/a | €71m |
| Jun 30 2021 | n/a | n/a | €81m |
| Mar 31 2021 | n/a | n/a | €77m |
| Dec 31 2020 | €420k | €300k | €73m |
| Sep 30 2020 | n/a | n/a | €51m |
| Jun 30 2020 | n/a | n/a | €28m |
| Mar 31 2020 | n/a | n/a | €16m |
| Dec 31 2019 | €295k | €234k | €3m |
| Sep 30 2019 | n/a | n/a | €816k |
| Jun 30 2019 | n/a | n/a | -€2m |
| Mar 31 2019 | n/a | n/a | -€2m |
| Dec 31 2018 | €328k | €234k | -€3m |
Compensation vs Market: Denis's total compensation ($USD1.35M) is above average for companies of similar size in the German market ($USD891.39K).
Compensation vs Earnings: Denis's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Denis Fortier (56 yo)
7.8yrs
Tenure
€1,300,000
Compensation
Mr. Denis Fortier is Non-Executive Director of Genome Diagnostics B.V. from 2022. He serves as the Chairman of the Board and Chief Executive Officer of Eurobio Scientific Société anonyme (also known as Dia...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Member of Management Board & Chairman | 7.8yrs | €1.30m | 0.057% € 146.1k | |
| Manager of Finance & IT and CFO | less than a year | €199.35k | no data | |
| GM, Member of Management Board & Director | 7.8yrs | €1.53m | no data | |
| COO and Operations | 1.6yrs | €301.22k | 0.029% € 74.9k | |
| CCO & Member of Management Board | less than a year | no data | no data | |
| CTO and Director of R&D | less than a year | no data | no data | |
| Vice President of Sales & Marketing | no data | no data | no data | |
| CHRO & Ressources Humaines | 1.4yrs | no data | no data | |
| Chief Business Officer | 11.3yrs | no data | no data | |
| CMO, COM and Manager of International Product | less than a year | no data | no data |
1.4yrs
Average Tenure
Experienced Management: E8TN's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Member of Management Board & Chairman | 1.6yrs | €1.30m | 0.057% € 146.1k | |
| GM, Member of Management Board & Director | no data | €1.53m | no data | |
| Director | no data | €392.34k | 0.036% € 91.9k | |
| Independent Director | 7.6yrs | €15.00k | no data | |
| Independent Director | 20.5yrs | €15.00k | 0.043% € 110.3k | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | no data | no data | no data |
7.6yrs
Average Tenure
64yo
Average Age
Experienced Board: E8TN's board of directors are considered experienced (7.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/06 01:23 |
| End of Day Share Price | 2025/01/06 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eurobio Scientific Société anonyme is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wang Chong | Edison Investment Research |
| Stephanie Lefebvre | Gilbert Dupont |
| Damien Choplain | Gilbert Dupont |